VBI Vaccines Inc. (Nasdaq: VBIV) has provided an update on its restructuring proceedings, initially announced on July 30, 2024. U.S. Chapter 15 Filing:On August 2, 2024, the U.S. Bankruptcy Court for the District of Delaware granted provisional relief under Chapter…
Owens & Minor, Inc. (NYSE: OMI) Announces Second Quarter Financial Results for 2024 Owens & Minor, Inc. (NYSE: OMI) has released its financial results for the second quarter ending June 30, 2024. Key Highlights: Edward A. Pesicka, President & CEO,…
BostonGene, a leader in AI-driven molecular and immune profiling solutions, has announced a new research collaboration with Takeda focused on immuno-oncology. This partnership aims to enhance clinical solutions and patient outcomes by pinpointing key molecular drivers and predictive markers of…
Twist Bioscience Corporation (NASDAQ: TWST), known for its high-quality synthetic DNA via its silicon platform, has reported its financial results and business highlights for the third quarter of fiscal 2024, ending June 30, 2024. Financial Performance Business Highlights Emily M.…
Adaptimmune Therapeutics plc (NASDAQ: ADAP) has announced that the U.S. FDA has granted accelerated approval for TECELRA® (afamitresgene autoleucel) as the first engineered cell therapy for treating solid tumors. This approval is specifically for adults with unresectable or metastatic synovial…
VSee Health, Inc. (Nasdaq: VSEE), known for its telehealth services that optimize workflows and improve patient care, has partnered with Ava Robotics, a leader in intelligent workplace robots. Together, they will develop telepresence solutions for the inpatient ICU market, including…
Eric Swaim, VP of Strategic Sourcing at HealthTrust Performance Group, has received Healthcare Purchasing News’ inaugural 40 Under 40 award. This honor highlights outstanding professionals in healthcare who are significantly impacting their organizations. HealthTrust Performance Group, a leader in healthcare…
Desktop Health, a leading brand in production-grade medical 3D printing from Desktop Metal, Inc. (NYSE: DM), has validated its Flexcera® Smile Ultra+ resin for use in dental implantology, specifically for All-on-X implant provisionals. Flexcera Smile Ultra+ is already FDA (510)k…
Medidata, a Dassault Systèmes company and a leading provider of clinical trial solutions, has announced that Eisai Incorporated, the U.S. subsidiary of Tokyo-based Eisai Co., Ltd., is among the first to implement the new Medidata Clinical Data Studio. This advanced…
Novaliq, a biopharmaceutical company specializing in innovative ocular therapies using EyeSol® waterless technology, has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Vevizye®. This product is aimed at…
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a frontrunner in AI-driven cardiovascular medicine, has unveiled its newly redesigned website, CDIO.AI. This upgraded platform underscores the Company’s commitment to an AI-first approach and showcases its advanced, scalable solutions for preventing, detecting, and…
Hologic, Inc. (Nasdaq: HOLX) has announced its financial results for the fiscal third quarter ending June 29, 2024. “We delivered another strong financial performance in Q3 2024, marked by sequential improvements in our operating margin and robust cash flow,” said…